Dublin, Feb. 14, 2017 -- Research and Markets has announced the addition of the "Cholera Forecast for selected Asian Markets 2017-2027" report to their offering.
Cholera is a bacterial disease caused by infection from Vibrio cholerae species (O1, O139), usually spread through contaminated water. Cholera causes severe diarrhoea and dehydration. Left untreated, cholera can be fatal in a matter of hours, even in previously healthy people.
This report provides the current incidence population for Cholera for Selected Asian Markets (Cambodia, Indonesia, Lao PDR, and Vietnam) split by gender and 5-year age cohort. Along with the current incidence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.
Providing a value-added level of insight from the analysis team, several of the main symptoms of Cholera have been quantified and presented alongside the overall incidence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.
Risk factors for contracting cholera relate mostly to contaminated water and sanitation. The disease shows marked seasonality in developing nations, and outbreaks can occur during natural disasters (tsunamis) and complex emergencies (generally affecting the water supply / sanitation infrastructure).
This report is built using data and information sourced from the proprietary patient segmentation database. To generate accurate patient population estimates, the database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.
Key Topics Covered:
1. Introduction
2. Cause of the Disease
3. Risk Factors & Prevention
4. Diagnosis of the Disease
5. Variation by Geography
6. Disease Prognosis & Clinical Course
7. Methodology for quantification of patient numbers
8. Top-line estimated incidence for Cholera
9. Cholera in Vietnam
10. Abbreviations used in the report
11. Patient-Based Offering
12. Online Pricing Data and Platforms
13. References
14. Appendix
For more information about this report visit http://www.researchandmarkets.com/research/vh5jzd/cholera_forecast
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infectious Diseases Drugs


San Francisco Suspect Arrested After Molotov Cocktail Attack on OpenAI CEO Sam Altman's Home
FedEx Pilots and Union Reach Tentative Agreement on 40% Pay Increase
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs
MATCH Act: How New U.S. Chip Legislation Could Freeze China's Semiconductor Ambitions
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses
Chinese Brands Are Taking Over Brazil — And It's Just Getting Started
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs 



